thalidomide has been researched along with Dysembryoma in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide has anti-inflammatory and anti-angiogenetic activity that makes it suitable for treating inflammatory bowel diseases (IBD)." | 8.91 | The clinical implications of thalidomide in inflammatory bowel diseases. ( Bracci, F; Capriati, T; Corsetti, T; Diamanti, A; Elia, D; Knafelz, D; Papadatou, B; Torre, G, 2015) |
| "Thalidomide has anti-inflammatory and anti-angiogenetic activity that makes it suitable for treating inflammatory bowel diseases (IBD)." | 4.91 | The clinical implications of thalidomide in inflammatory bowel diseases. ( Bracci, F; Capriati, T; Corsetti, T; Diamanti, A; Elia, D; Knafelz, D; Papadatou, B; Torre, G, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamanti, A | 1 |
| Capriati, T | 1 |
| Papadatou, B | 1 |
| Knafelz, D | 1 |
| Bracci, F | 1 |
| Corsetti, T | 1 |
| Elia, D | 1 |
| Torre, G | 1 |
| Grushka, JR | 1 |
| Ryckman, J | 1 |
| Mueller, C | 1 |
| Roessingh, Ade B | 1 |
| Walton, JM | 1 |
| St Vil, D | 1 |
| Laberge, JM | 1 |
| Bernard, C | 1 |
| Nguyen, VH | 1 |
| Puligandla, PS | 1 |
2 reviews available for thalidomide and Dysembryoma
| Article | Year |
|---|---|
The clinical implications of thalidomide in inflammatory bowel diseases.
Topics: Child; Europe; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Teratoma; Thalidomide; | 2015 |
Spindle epithelial tumor with thymus-like elements of the thyroid: a multi-institutional case series and review of the literature.
Topics: Abscess; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Celecoxib; Ch | 2009 |